Evidence map›Paper›PMID 32923984›Full record

ArticleHemaSphere2020

Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.

Anil K Deshantri, Marcel H A M Fens, Ruud W J Ruiter, Josbert M Metselaar, Gert Storm, Sanjay N Mandhane, Gerard H M Graat, Eef G W Lentjes, Huipin Yuan, Joost D de Bruijn and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Recent advances in targeted drug delivery systems for multiple myeloma.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Anil K DeshantriDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Marcel H A M FensDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Ruud W J RuiterDepartment of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Josbert M MetselaarEnceladus Pharmaceuticals, Naarden, the Netherlands.
Gert StormDepartment of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Sanjay N MandhaneBiological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd. Vadodara, India.
Gerard H M GraatDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Eef G W LentjesDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Huipin YuanKuros Biosciences BV, Bilthoven, The Netherlands.
Joost D de BruijnKuros Biosciences BV, Bilthoven, The Netherlands.
Tuna MutisDepartment of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Anton C M MartensDepartment of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Richard W J GroenDepartment of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Raymond M SchiffelersDepartment of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Amsterdam UMC Location VUmc · NLCancer Center AmsterdamSun Pharma Advanced Research (India) · INUniversity Medical Center Utrecht · NLEnceladus Pharmaceuticals (Netherlands) · NLNetherlands Metabolomics Centre · NLPharmo Institute · NLUniversity of Twente · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32923984
PMCPMC7455224
OpenAlexW3082071662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.